首页> 外文期刊>Annals of clinical biochemistry. >Diagnostic applications of newborn screening for alpha-thalassaemias, haemoglobins E and H disorders using isoelectric focusing on dry blood spots
【24h】

Diagnostic applications of newborn screening for alpha-thalassaemias, haemoglobins E and H disorders using isoelectric focusing on dry blood spots

机译:等电聚焦于干血斑的新生儿筛查α地中海贫血,血红蛋白E和H疾病的诊断应用

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Neonatal screening for haemoglobin (Hb) disorders is a standard of care in several developed countries with the main objective to detect Hb S. Such practice has not been established in Thailand where alpha-thalassaemia and haemoglobin E (Hb E) are highly prevalent. Early identification of thalassaemias could be helpful and strengthen the programme for prevention and control for severe thalassaemias. Methods: Data from isoelectric focusing (IEF) and Isoscan~R for detecting types and amount (%) of each haemoglobin in 350 newborn's dried blood spots were analysed and compared with the comprehensive genotype analysis by DNA studies as a gold standard. Results: Based on genetic profiles, there were 10 different categories: (I) normal (n = 227), (2) alpha~+-thalassaemia trait (n = 14), (3) alpha~0-thalassaemia trait (n = 13), (4) beta~0-thalassaemia trait (n = 7), (5) Hb E trait (n = 72), (6) Hb E trait with alpha~0-thalassaemia or homozygous alpha~+-thalassaemia (n = 5), (7) Hb E trait with alpha~+-thalassaemia trait (n = 5), (8) homozygous Hb E (n = 3), (9) homozygous Hb E with alpha~0-thalassaemia trait (n = I) and (10) Hb H disease (n = 3). The presence of Hb Bart's and Hb E were used to identify cases with a-thalassaemia and Hb E, respectively. We set 0.25% of Hb Bart's and 1.5% of Hb E as a cut-off level to detect alpha~+-thalassaemia trait (sensitivity 92.86% and specificity 74.0%) and Hb E trait with 100% of both sensitivity and specificity for IEF diagnosis. Conclusion: Although molecular diagnosis seems to be better for definitive diagnosis of thalassaemia syndromes at birth, however, using our reference range described herein, IEF can be applied in a resource-limiting setting with acceptable reliability.
机译:背景:在一些发达国家,新生儿筛查血红蛋白(Hb)疾病是一项护理标准,其主要目标是检测HbS。在泰国,α-地中海贫血和血红蛋白E(Hb E)高度流行,这种做法尚未建立。早期识别地中海贫血可能会有所帮助,并加强预防和控制严重地中海贫血的计划。方法:对来自等电聚焦(IEF)和Isoscan〜R的数据进行检测,以检测350例新生儿干血斑中每种血红蛋白的类型和含量(%),并将其与以DNA研究为基础的综合基因型分析作为金标准进行比较。结果:根据遗传特征,有10种不同的类别:(I)正常(n = 227),(2)α〜+地中海贫血性状(n = 14),(3)alpha〜0地中海贫血性状(n = 13),(4)β〜0地中海贫血性状(n = 7),(5)Hb E性状(n = 72),(6)具有α〜0地中海贫血或纯合性α〜+地中海贫血的Hb E性状( n = 5),(7)具有α〜+地中海贫血特征的Hb E性状(n = 5),(8)具有纯合的Hb E(n = 3),(9)具有α〜0地中海贫血特征的纯合性Hb E( n = I)和(10)Hb H病(n = 3)。 Hb Bart's和Hb E的存在分别用于鉴定地中海贫血和Hb E的病例。我们将0.25%的Hb Bart's和1.5%的Hb E作为临界水平,以检测α〜+地中海贫血性状(敏感性92.86%和特异性74.0%)和Hb E性状,对IEF的敏感性和特异性均为100%诊断。结论:尽管分子诊断似乎对出生时地中海贫血综合征的确切诊断更好,但是,使用本文所述的参考范围,IEF可以可靠的应用于资源有限的环境中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号